how long have glp 1 drugs been around Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review | GLP-1 Drugs Market Size to
Description
& Norris, K
After 12 weeks of treatment, there were no differences between the groups
Do GLP-1-based therapies increase cancer risk
doi: 10.1186/s12950-019-0218-y 46 Posso-OsorioIVargas-PotesCJMejaMCaasCA
Mayendraraj A, Rosenkilde MM, Gasbjerg LS
Healthcare professionals should provide comprehensive counselling about realistic expectations, potential side effects, and the importance of lifestyle modifications alongside pharmacotherapy for optimal outcomes in cardiometabolic health
